Romidepsin (GMP) (FK 228 (GMP)) is Romidepsin (HY-15149) produced by using GMP guidelines. GMP small molecules works appropriately as an auxiliary reagent for cell therapy manufacture. Romidepsin (FK 228) is a Histone deacetylase (HDAC) inhibitor with anti-tumor activities. Romidepsin (FK 228) inhibits HDAC1, HDAC2, HDAC4, and HDAC6 with IC50s of 36 nM, 47 nM, 510 nM and 1.4 μM, respectively. Romidepsin (FK 228) is produced by Chromobacterium violaceum, induces cell G2/M phase arrest and apoptosis.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- Formule: C24H36N4O6S2
- Masse moléculaire:540.70
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Activité biologique
-
Chemical Information
- Pureté et documentation
- Références
-
Help & FAQs
Activité biologique
Romidepsin (GMP) (0-72 hours; 0-80 nM) inhibits proliferation of HCC cells in dose-dependent manner[2]. Romidepsin (GMP) (0-48 hours; 0-60 nM) leads to a time- and dose-dependent induction of cell cycle arrest in the G2/M phase in HCC cells[2]. Romidepsin (GMP) (0-48 hours; 0-60 nM) promotesapoptosis in HCC cells, increases c-caspase-3, c-caspase-9, and c-PARP protein expression[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:HCC cells
-
Concentration:0 nM; 10 nM; 20 nM; 30 nM; 40 nM; 50 nM; 60 nM; 70 nM; 80 nM
-
Incubation Time:0 hours; 12 hours; 24 hours; 48 hours; 72 hours
-
Result:Inhibited HCC cells proliferation.
-
Cell Line:HCC cells
-
Concentration:0 nM; 15 nM; 30 nM; 60 nM
-
Incubation Time:12 hours; 24 hours; 48 hours
-
Result:Caused a G2/M arrest.
-
Cell Line:HCC cells
-
Concentration:0 nM; 15 nM; 30 nM; 60 nM
-
Incubation Time:12 hours; 24 hours; 48 hours
-
Result:Increaesd c-caspase-3, c-caspase-9, and c-PARP expression in HCC cells.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Nude mice with Huh7 cells[2]
-
Dosage:0.5 and 1 mg/kg
-
Administration:Intraperitoneal injection; 0.5 and 1 mg/kg; every 3 day; 21 days
-
Result:Suppressed tumor growth in mouse xenograft models.
Chemical Information
-
Masse moléculaire 540.70
-
Formule C24H36N4O6S2
-
SMILES
C/C=C(NC([C@@H](CSSCC/C=C/[C@@H](O1)CC2=O)NC([C@@H](C(C)C)N2)=O)=O)/C(N[C@@H](C(C)C)C1=O)=O
-
Synonyms
FK 228 (GMP); FR 901228 (GMP); NSC 630176 (GMP)
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureté et documentation
Références
[1]. Furumai R, et al. FK228 (depsipeptide) as a natural prodrug that inhibits class I histone deacetylases. Cancer Res. 2002 Sep 1;62(17):4916-21. [Content Brief]
[2]. Sun WJ, et al. Romidepsin induces G2/M phase arrest via Erk/cdc25C/cdc2/cyclinB pathway and apoptosis induction through JNK/c-Jun/caspase3 pathway in hepatocellular carcinoma cells. Biochem Pharmacol. 2017 Mar 1;127:90-100. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Romidepsin (GMP) Related Classifications
HY-15149G Related Classifications
Powered by Bioz